Amid Coronavirus Outbreak, FDA and Industry Seek Roadmap

Evaluation of Chagas RDTs Shows High Accuracy in Endemic Region

FDA Approves Diagnostic Test for Zika Virus

Seattle's InBios: First to Receive FDA Authorization for Zika Test

First Diagnostic Test for Zika Gets FDA's OK to Market

InBios Receives FDA Market Authorization for its ZIKV Detect 2.0 IgM Capture ELISA for a Presumptive Diagnosis of Zika Virus Infection

FDA Grants Marketing Authorization for First Diagnostic Test for Detecting Zika IgM Antibodies to InBios

InBios announces FDA clearance of its Dengue NS1 ELISA kit

InBios announces FDA emergency use authorization for its Zika ELISA

As Zika Virus Spreads, Gaps In Diagnostic Testing Present Opportunities For Drug Companies